MARATTO

article · PubMed

[Iridoschisis: a rare condition].

Abstract

Iridoschisis, a rare degenerative condition, is defined by atrophy of the iris associated with cleavage of the iris stroma, the anterior part of which disintegrates into fibrils floating in the Anterior chamber (AC). Iris involvement is bilateral, progressive but not transfixing, respecting the pigment epithelium and often localised in the lower sector. Diagnosis is clinical. Optical coherence tomography of the anterior segment (OCT-SA) provides characteristic semiological features. The main differential diagnoses are irido-corneo-endothelial syndrome and Axenfeld-Rieger syndrome. Association with angle-closure glaucoma (ACG) is reported in 2/3 of cases. The mechanism of hypertonia is thought to be twofold: failure of the trabecular meshwork to evacuate Aqueous humour (AH) through iris debris and resistance of the iridolenticular interface to the flow of AH, resulting in pupillary block. A 71-year-old patient with no previous pathological history consulted for a red and painful left eye in connection with an acute angle-closure crisis. After resolution of the crisis by hypotonising treatment, examination showed a narrow CA (A), an atrophic iris inferiorly cleaved into fibrils floating in the HA (B). Gonioscopy showed a closed Iridocorneal angle (ICA) in the absence of anterior synechiae. OCT-SA showed cleavage and disorganisation with a mottled appearance of the anterior part of the iris stroma respecting the iris pigment epithelium (C), a closed ICA and a narrow CA (D). All these features supported the diagnosis of iridoschisis associated with an AFM crisis.

Research topics

  • Congenital Anomalies and Fetal Surgery

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.11604/pamj.2024.49.135.45888

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.